Valuation: Kenvue Inc.

Market Cap 33.82B 29.75B 28.05B 25.59B 47.85B 3,247B 48.23B 337B 130B 1,653B 127B 124B 5,377B P/E 2026 *
18.6x
P/E 2027 * 16.2x
Enterprise Value 40.92B 36B 33.93B 30.96B 57.9B 3,928B 58.35B 407B 158B 1,999B 154B 150B 6,506B EV / Sales 2026 *
2.62x
EV / Sales 2027 * 2.53x
Free-Float
98.88%
Yield 2026 *
4.79%
Yield 2027 * 4.89%
1 day-0.34%
1 week-1.45%
Current month-6.73%
1 month-9.37%
3 months-6.33%
6 months+0.34%
Current year+2.09%
1 week 17.49
Extreme 17.49
17.99
1 month 17.49
Extreme 17.49
19.47
Current year 16.56
Extreme 16.555
20.13
1 year 14.02
Extreme 14.02
20.13
3 years 14.02
Extreme 14.02
25.17
5 years 14.02
Extreme 14.02
27.8
10 years 14.02
Extreme 14.02
27.8
Manager TitleAgeSince
Chief Executive Officer 56 2025-07-13
Director of Finance/CFO 48 2026-05-11
Chief Tech/Sci/R&D Officer 57 -
Director TitleAgeSince
Chairman 70 2023-04-30
Director/Board Member 66 2023-05-03
Director/Board Member 59 2023-05-07
Date Insider Type Main position Quantity % Market Cap. Importance
7/31/26 Exercice

Executive/Senior Manager

32,838 0.0017%
5/21/26 Free

Director

10,309 0.0005%
5/21/26 Free

Chairman

16,036 0.0008%
Change 5-day change 1-year change 3-year change Capi.($)
-0.34%-1.45%+4.45%-14.31% 33.94B
-1.16%-1.27%-4.42%-3.89% 342B
+0.67%+1.64%-6.07%+1.68% 134B
-0.71%-2.75%+5.16%+17.76% 68.5B
-0.85%-0.45%-24.16%-22.11% 47.83B
-3.50%+1.61%+11.77%-35.39% 35.76B
+1.18%+1.44%+8.29%+29.21% 19.87B
+2.98%+4.18%-11.54%-37.93% 18.86B
-0.88%-1.48%+7.87%+11.86% 17.97B
-0.54%+0.23%-26.22%-11.27% 9.4B
Average -0.13%+0.62%-3.49%-6.44% 72.8B
Weighted average by Cap. +0.18%-0.36%-3.73%-3.75%

Financials

2026 *2027 *
Net sales 15.6B 13.72B 12.93B 11.8B 22.06B 1,497B 22.24B 155B 60.13B 762B 58.55B 57.28B 2,479B 15.97B 14.04B 13.24B 12.08B 22.59B 1,533B 22.77B 159B 61.57B 780B 59.95B 58.65B 2,538B
Net income 1.83B 1.61B 1.51B 1.38B 2.58B 175B 2.61B 18.18B 7.05B 89.26B 6.86B 6.71B 290B 2.1B 1.85B 1.74B 1.59B 2.97B 202B 3B 20.91B 8.1B 103B 7.89B 7.72B 334B
Net Debt 7.1B 6.24B 5.89B 5.37B 10.04B 682B 10.12B 70.64B 27.38B 347B 26.66B 26.08B 1,129B 6.53B 5.75B 5.42B 4.94B 9.24B 627B 9.31B 65B 25.19B 319B 24.53B 23.99B 1,039B
Logo Kenvue Inc.
Kenvue Inc. is one of the world leaders in the design, manufacture and marketing of consumer healthcare products. The group offers products for health, beauty, baby care, oral care, skin care and more. Net sales break down by family of products as follows: - self care products (42,3%): for the treatment of coughs, colds, allergies, pain, indigestion, constipation, etc. (brands Zyrtec, Benadryl, Zarbee's, Frenadol, Codral, Reactine, Tylenol, Motrin, Calpol, Nicorette, Imodium, Pepcid, Microlax, Daktarin, etc.); - personal care products (30.3%): primarily oral care, baby care, women's health and wound care products (Listerine, Desitin, Carefree, Stayfree, Band-Aid, Neosporin brands, etc.); - beauty and skin care products (27.4%): hair care products, sun protection products, face and body care products, etc. (Neutrogena, Aveeno, Clean&Clear, Lubriderm, Johnsons, Neostrata, OGX, Rogaine brands, etc.). Product marketing is assured through direct sales, distributors and the Internet. Net sales are distributed geographically as follows: North America (49%), Europe-Middle East-Africa (23%), Asia-Pacific (19.3%) and Latin America (8.7%).
Employees
21,890
Date Price Change Volume
26-09-24 US$17.61 -0.34% 17,494,154
26-09-23 US$17.67 -1.06% 16,168,563
26-09-22 US$17.86 +1.08% 14,290,325
26-09-21 US$17.67 -0.79% 25,683,360
26-09-18 US$17.81 -0.34% 26,721,864
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
17.61USD
Average target price
19.50USD
Spread / Average Target
+10.73%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. KVUE Stock